Cystic fibrosis (CF) is caused
by a mutation
in a gene called
the cystic fibrosis transmembrane
conductance regulator.
That's the science - but the reality
for patients with this life-threatening
disease can be hard.
What is GSK
doing to help them?
19 September 2008
GSK update on FDA review of Promacta® (eltrombopag)
16 September 2008
New data for GlaxoSmithKline’s pre-pandemic H5N1 influenza vaccine, Prepandrix™, show administration flexibility for pandemic planning
16 September 2008
GSK and Xenoport announce submission of new drug application requesting FDA approval of Solzira™ for Restless Legs Syndrome
![]()